199328-35-3

Basic information

• Product Name: BENZENEACETIC ACID, 4-BROMO-2-NITRO-, ETHYL ESTER
• Synonyms: BENZENEACETIC ACID, 4-BROMO-2-NITRO-, ETHYL ESTER;(4-Bromo-2-nitro-phenyl)-acetic acid ethyl ester;Ethyl 2-(4-bromo-2-nitrophenyl)
• CAS NO: 199328-35-3
• Molecular Formula: C₁₀H₁₀BrNO₄
• Molecular Weight: 288.096
• Mol File: 199328-35-3.mol
• Article Data: 7

Chemical Properties

• Boiling Point: 345℃
• Flash Point: 163℃
• Appearance: /
• Density: 1.542
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: BENZENEACETIC ACID, 4-BROMO-2-NITRO-, ETHYL ESTER(CAS DataBase Reference)
• NIST Chemistry Reference: BENZENEACETIC ACID, 4-BROMO-2-NITRO-, ETHYL ESTER(199328-35-3)
• EPA Substance Registry System: BENZENEACETIC ACID, 4-BROMO-2-NITRO-, ETHYL ESTER(199328-35-3)

Safety Data

• Hazardous Substances Data: 199328-35-3(Hazardous Substances Data)

Usage

General Description

Benzeneacetic Acid, 4-Bromo-2-Nitro-, Ethyl Ester is a synthetic chemical with the molecular formula C10H10BrNO4. It is largely used in the pharmaceutical industry for making various types of drugs. The chemical is white to light yellow in colour and generally appears in crystalline or powder form. It is non-flammable but can emit toxic fumes when heated, and direct contact may cause skin and eye irritation. Handling it requires safety equipment due to its harmful nature.

Upstream product

• 1098855-11-8 C₉H₆BrNO₆ 
• 64-17-5 ethanol 
• 199328-34-2 diethyl 2-(4-bromo-2-nitrophenyl)malonate 
• 364-73-8 4-Bromo-1-fluoro-2-nitrobenzene 
• 3460-18-2 1,4-dibromo-2-nitrobenzene 

Downstream Products

• 1357259-26-7 C₁₂H₁₄BrNO₄ 
• 887398-45-0 C₃₃H₃₁F₃N₆O₃ 
• 887398-46-1 C₃₁H₂₆F₃N₅O₃ 
• 1353643-96-5 C₂₁H₁₈N₄O₂ 
• 1033768-17-0 1-(3-((3-((1H-pyrrol-2-yl)methylene)-2-oxoindolin-6-yl)amino)phenyl)-3-(3-(trifluoromethyl)phenyl)urea 
• 1033768-70-5 C₂₈H₂₂F₃N₅O₂ 
• 1033769-28-6 1-(3-((3-((1H-pyrrol-2-yl)methylene)-2-oxoindolin-6-yl)amino)-4-methylphenyl)-3-(2-fluoro-5-(trifluoromethyl)phenyl)urea 
• 887397-98-0 C₂₆H₂₀N₄O₂ 
• 887399-27-1 6-(3-aminophenylamino)indolin-2-one 
• 1353643-97-6 C₂₆H₁₉FN₄O₂ 
• 887397-99-1 N-(3-((3-((1H-pyrrol-2-yl)methylene)-2-oxoindolin-6-yl)amino)phenyl)-3-(trifluoromethyl)benzamide 
• 1369963-41-6 C₁₆H₁₅N₃O₂ 
• 1369963-42-7 C₂₁H₁₇N₃O₂ 
• 1369963-64-3 C₂₁H₁₆FN₃O₂ 

Relevant articles and documents

FUSED RING COMPOUNDS AS HEPATITIS C VIRUS INHIBITORS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF

Provided are fused tricyclic compounds effective to inhibit the function of the NS5A protein of formula (I), wherein X, X', Y, Y', A, A',Q1, Q2, R1-R4, X4, R5a, f and W are defined as in the description. Also provided herein are pharmaceutical compositions thereof, and uses in the manufacture of a medicament for treating HCV infection or a HCV disorder thereof.

Discovery of GNF-5837, a selective TRK inhibitor with efficacy in rodent cancer tumor models

Neurotrophins and their receptors (TRKs) play key roles in the development of the nervous system and the maintenance of the neural network. Accumulating evidence points to their role in malignant transformations, chemotaxis, metastasis, and survival signaling and may contribute to the pathogenesis of a variety of tumors of both neural and non-neural origin. By screening the GNF kinase collection, a series of novel oxindole inhibitors of TRKs were identified. Optimization led to the identification of GNF-5837 (22), a potent, selective, and orally bioavailable pan-TRK inhibitor that inhibited tumor growth in a mouse xenograft model derived from RIE cells expressing both TRKA and NGF. The properties of 22 make it a good tool for the elucidation of TRK biology in cancer and other nononcology indications.

Monofluoroalkyl derivatives

The present invention provides certain monofluoroalkyl derivatives useful for potentiating glutamate receptor function in a mammal and therefore, useful for treating a wide variety of conditions, such as psychiatric and neurological disorders.